Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
US-10694972-B2 · Jun 30, 2020 · US
US10918852B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10918852-B2 |
| Application number | US-201916573644-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 17, 2019 |
| Priority date | Nov 13, 2017 |
| Publication date | Feb 16, 2021 |
| Grant date | Feb 16, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A nanodevice includes an array of metal nanorods formed on a substrate. An electropolymerized electrical conductor is formed over tops of a portion of the nanorods to form a reservoir between the electropolymerized conductor and the substrate. The electropolymerized conductor includes pores that open or close responsively to electrical signals applied to the nanorods. A cell loading region is disposed in proximity of the reservoir, and the cell loading region is configured to receive stem cells. A neurotrophic dispensing material is loaded in the reservoir to be dispersed in accordance with open pores to affect growth of the stem cells when in vivo.
Opening claim text (preview).
What is claimed is: 1. A nanodevice, comprising: an electropolymerized electrical conductor formed over tops of nanorods to form a reservoir between the electropolymerized electrical conductor and a substrate, the electropolymerized electrical conductor including pores that open and close responsively to electrical signals applied to the nanorods; a cell loading region configured to receive cells; and a neurotrophic dispensing material loaded in the reservoir, the neurotrophic dispensing material being dispersed when the pores are open to affect growth of the cells when in vivo. 2. The nanodevice as recited in claim 1 , wherein the electropolymerized electrical conductor includes electrically conductive polymers selected from the group consisting of polypyrrole, polyanilines, poly(thiophene), poly(3,4-ethylenedioxythiophene), poly(p-phenylene sulfide), poly(p-phenylene vinylene), poly(acetylene) and a combination thereof. 3. The nanodevice as recited in claim 1 , wherein the substrate includes a semiconductor material and further comprises a control circuit formed in the substrate to control activation of electrodes formed by the nanorods. 4. The nanodevice as recited in claim 1 , wherein the neurotrophic dispensing material includes a neurotrophin selected from the group consisting of brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4 (NT-4) and nerve growth factor (NGF). 5. The nanodevice as recited in claim 1 , wherein the electrical signals are pulsed to control an amount of neurotrophic dispensing material released. 6. The nanodevice as recited in claim 1 , wherein the cell loading region is configured to use a gel media to receive the cells. 7. The nanodevice as recited in claim 1 , wherein the cell loading region is configured to use an electrical charge to receive the cells. 8. The nanodevice as recited in claim 1 , wherein the cells are stem cells. 9. The nanodevice as recited in claim 8 , wherein the cells are neuro-stem cells.
Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3 · CPC title
for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) · CPC title
Arrangements or circuits for monitoring, protecting, controlling or indicating {(for external stimulators A61N1/3603; for implantable neurostimulators A61N1/36128; for heart stimulators A61N1/37; for defibrillators A61N1/3925)} · CPC title
Electrodes {(electrosurgical electrodes A61B18/14)} · CPC title
Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.